Dyfyniad APA

Deng, Y., Wang, L., Tan, S., Kim, G. P., Dou, R., Chen, D., . . . Wang, J. (2015). KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer. Mol Oncol.

Dyfyniad Arddull Chicago

Deng, Yanhong, et al. "KRAS As a Predictor of Poor Prognosis and Benefit From Postoperative FOLFOX Chemotherapy in Patients With Stage II and III Colorectal Cancer." Mol Oncol 2015.

Dyfyniad MLA

Deng, Yanhong, et al. "KRAS As a Predictor of Poor Prognosis and Benefit From Postoperative FOLFOX Chemotherapy in Patients With Stage II and III Colorectal Cancer." Mol Oncol 2015.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.